Lowell Thomas Holden, CFO at Nascent Biotech Inc. (NBIO), bought 61,700 shares at $0.17 ($7K) on 2019-12-26, disclosed to the SEC on 2020-01-06.
Open-market purchase of $7k NBIO by CFO. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $0.17 | 5,000 | $850 | 13.0% |
| 2 | $0.10 | 56,700 | $6K | 87.0% |
| Total | $0.11 avg | 61,700 | $7K | 100% |
| Filing → |
| NBIO | BUY | 2023-02-02 | $3K | — | Filing → |
| NBIO | SELL | 2022-07-25 | $1K | — | Filing → |
| SKKY | BUY | 2022-04-11 | $2K | — | Filing → |